ensun logo
Locations
Company type
Result types
Industries
Employees
Founding year
Sandoz International Logo

Sandoz International

Sandoz introduces Act4Biosimilars Action Plan to accelerate patient access to biosimilar medicines. Sandoz presents compelling investment proposition as standalone company at Capital Markets Day. Sandoz plans move to new central Basel headquarters by mid-2024, following proposed spin-off as standalone company. Sandoz strengthens pipeline expansion through partnership to develop and manufacture multiple biosimilars. Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines.

Quick overview

Holzkirchen, Germany

Founded in 1886

10001+ Employees

Additional information

Working industry

Pharmaceuticals

Type of company

Service provider, Manufacturer

Ownership structure

Public Company

Locations

3 Locations

Number of products

16 Products

Specialised areas

Pharmaceutical, Pharmaceuticals, Manufacturing, Medical

Products & services of Sandoz International

Sandoz International offers a wide range of products and services

Product: Sandoz Biosimilar Portfolio | novartis

Product

Sandoz Biosimilar Portfolio | novartis

Go to product >

Product: Partnerships and Collaborations | novartis

Product

Partnerships and Collaborations | novartis

Go to product >

Product: Value of Biosimilars | novartis

Product

Value of Biosimilars | novartis

Go to product >

Product: Information for Patients | novartis

Product

Information for Patients | novartis

Go to product >

Product: Disease Areas | novartis

Product

Disease Areas | novartis

Go to product >

Product: Over-The-Counter Medicines | novartis

Product

Over-The-Counter Medicines | novartis

Go to product >

Product: Anti-Infectives | novartis

Product

Anti-Infectives | novartis

Go to product >

Product: The Science of Biosimilars | novartis

Product

The Science of Biosimilars | novartis

Go to product >

ESG score estimation

An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself

Country:

Germany


Overall risk estimation:

Very low


ESG country scores

The ESG Data of countries are based on public sources

Environment

A

Grade (A-E)

View details

Social

A

Grade (A-E)

View details

Governance

A

Grade (A-E)

View details

Headquarter of Sandoz International

Sandoz International operates in 2 countries around the world

City: Holzkirchen

State: Bavaria

Country: Germany

Locations of Sandoz International

Get an overview of the locations of Sandoz International

Location

Country

State

City

Headquarter

Germany

Bavaria

Holzkirchen

Sandoz International GmbH

Germany

Bavaria

Holzkirchen

Sandoz Inc.

United States

New Jersey

Princeton

Frequently asked questions (FAQ) about Sandoz International

Some frequent questions that have been asked about Sandoz International

The company headquarter of Sandoz International is located in Holzkirchen, Bavaria, Germany. Sandoz International has subsidiaries in Germany, United States

As of the latest available information Sandoz International has around 10001+ employees worldwide.

Sandoz International was founded in 1886

The company Sandoz International has it's main focus in the industries of Pharmaceuticals

Competitors of Sandoz International

Check out some interesting alternative companies to Sandoz International

Sandoz Inc.'s Logo

Sandoz Inc.

Princeton, United States

1001-5000 Employees

-

Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people’s lives. Our diverse and dynamic teams work colaborativelly to bring innovative products and ideas to life. This site is intended for a US audience.

Sandoz Canada's Logo

Sandoz Canada

Boucherville, Canada

10001+ Employees

1980

Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people’s lives. As a leader in generics with a growing portfolio of consumer, specialty and biosimilar products, Sandoz is pioneering novel approaches. This site is intended for an audience in Canada.

SANDOZ PTY LTD's Logo

SANDOZ PTY LTD

Sydney, Australia

501-1000 Employees

1996

Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people’s lives. Our diverse and dynamic teams work colaborativelly to bring innovative products and ideas to life. This site is intended for an audience in Australia.

Sandoz's Logo

Sandoz

Vilvoorde, Belgium

101-250 Employees

1996

Sandoz is een wereldleider op het gebied van generische geneesmiddelen en biosimilars. Sandoz is een wereldleider op het gebied van generische geneesmiddelen en biosimilars en maakt deel uit van de Novartis-groep. Onze missie bestaat erin nieuwe manieren te ontdekken om om het leven van mensen te verbeteren en te verlengen. Sandoz onderzoekt innovatieve benaderingen om mensen wereldwijd toegang te bieden tot hoogkwalitatieve geneesmiddelen. Op deze manier helpen we de maatschappij tegemoet te komen aan de toenemende behoefte van betaalbare gezondheidszorg.

Sandoz, S.A. de C.V.'s Logo

Sandoz, S.A. de C.V.

Mexico

11-50 Employees

-

Sandoz es la compañía líder en medicamentos genéricos y biocomparables con principal sede en Holzkirchen, Munich. Trabajamos continuamente para descubrir formas innovadoras para brindar soluciones asequibles y de alta calidad a la población que las necesitan.

Biosimilaren.se's Logo

Biosimilaren.se

Copenhagen, Denmark

51-100 Employees

2003

Vi är en del av Novartis och var först i världen med att få en biosimilar godkänd när tillväxthormonet somatropin godkändes av den europeiska läkemedelsmyndigheten, EMEA, 2006.5 Senare blev Sandoz även först med att få en biosimilar godkänd i USA. Vår vision är att alla ska ha tillgång till bästa tänkbara behandling. Men alla erbjuds den inte, eftersom behandlingen är dyr. Hur bra är din region på att erbjuda behövande patienter biosimilarer? Hur stor är användningen av respektive substans och hur har den förändrats jämfört med föregående kvartal? Hur stor användningen av biosimilarer är i varje region och hur den har förändrats jämfört med föregående kvartal. Biosimilarindex är ett mått på vilken roll biosimilarer spelar i den svenska hälso- och sjukvården. Ett lågt värde innebär att användningen av biosimilarer är låg.